» Articles » PMID: 28749714

Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Meta-Analysis

Overview
Publisher Mary Ann Liebert
Date 2017 Jul 28
PMID 28749714
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has been rapidly emerging as a life-threatening nosocomial disease in many countries. However, studies on the corresponding risk factors of CRKP infection showed inconsistent results. To resolve these inconsistencies, we conducted a meta-analysis of previous studies on the potential risk factors of CRKP infection. The results of this study could be used to develop CRKP infection prevention strategies.

Methods: Relevant works were systematically searched from five electronic databases up to September 2016. Z-test was used to determine the significance of the pooled odds ratios (ORs). ORs and 95% confidence intervals were utilized to compare the risk factors of CRKP infection.

Results: Sixteen studies that involved 3,627 participants were included in the meta-analysis. We identified the following risk factors that were associated with CRKP infection: (1) longer length of hospital stay (LOS) (OR = 12.92), (2) admission to intensive care unit (ICU) (OR = 2.48), (3) prior hospitalization (OR = 1.85), (4) longer days of ICU stay (OR = 4.58), (5) transplant recipient (OR = 2.01), (6) steroid use (OR = 1.43), (7) central venous catheter use (OR = 2.30), (8) mechanical ventilation (OR = 2.54), (9) presence of tracheostomy (OR = 3.63), (10) parenteral nutrition (OR = 2.38), (11) previous antibiotic use (OR = 3.31), and (12) exposure to carbapenems (OR = 4.01), (13) aminoglycosides (OR = 2.05), (14) glycopeptides (OR = 2.40), (15) quinolones (OR = 2.28), and (16) anti-pseudomonal penicillins (OR = 2.67).

Conclusions: Sixteen risk factors including longer LOS, admission to ICU, previous antibiotic use, and exposure to carbapenems were associated with the development of CRKP infection. Identification of modifiable risk factors could play an important role in the prevention of CRKP infection.

Citing Articles

Carbapenem-resistant infections after liver transplantation: Drug resistance, risk factors and impact on prognosis.

Liu T, Chen L, Wan Q World J Gastroenterol. 2025; 31(8):98415.

PMID: 40062326 PMC: 11886520. DOI: 10.3748/wjg.v31.i8.98415.


Comparative analysis of clinical characteristics and outcomes between carbapenem-resistant and carbapenem-sensitive infections: insights from a tertiary hospital in Northern China.

Wang B, Zhang W, Zhang H, Li M, Zhang Z, Peng X Front Med (Lausanne). 2025; 12:1499057.

PMID: 39975685 PMC: 11836024. DOI: 10.3389/fmed.2025.1499057.


Molecular Epidemiological Characteristics of -Carrying ST-11 in Hospitalized Patients.

Xue Y, Zhang D, Du S, Chen D, Liu S, Peng T Infect Drug Resist. 2025; 18():171-184.

PMID: 39803303 PMC: 11725253. DOI: 10.2147/IDR.S482713.


Donor-derived carbapenem-resistant Klebsiella Pneumoniae infections leading to retroperitoneal abscesses in kidney transplant recipients: a report of two cases.

Gao X, Chen L, Yang S, Zhu C, Wang D BMC Infect Dis. 2024; 24(1):1459.

PMID: 39716130 PMC: 11667997. DOI: 10.1186/s12879-024-10372-6.


Community-Acquired Pneumonia in Adults: A Mono-Center Retrospective Study.

Khorvash F, Hakamifard A, Esmaeili Sharif A, Mahmoudzadeh Zali M, Motamedi N, Ghiasi F Tanaffos. 2024; 23(1):11-29.

PMID: 39703444 PMC: 11655007.


References
1.
MacVane S . Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections. J Intensive Care Med. 2016; 32(1):25-37. DOI: 10.1177/0885066615619895. View

2.
Kritsotakis E, Tsioutis C, Roumbelaki M, Christidou A, Gikas A . Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011; 66(6):1383-91. DOI: 10.1093/jac/dkr116. View

3.
Delahaye F, Landrivon G, Ecochard R, Colin C . Meta-analysis. Health Policy. 1990; 19(2-3):185-96. DOI: 10.1016/0168-8510(91)90007-k. View

4.
Bogan C, Kaye K, Chopra T, Hayakawa K, Pogue J, Lephart P . Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control. 2014; 42(6):612-20. DOI: 10.1016/j.ajic.2014.02.013. View

5.
Kwak Y, Choi S, Choo E, Chung J, Jeong J, Kim N . Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist. 2005; 11(2):165-9. DOI: 10.1089/mdr.2005.11.165. View